Insomnia Mental and Behavioural Disorders Symptoms of insomnia
Conditions
Interventions
Fifty participants will be recruited and participant allocation will occur with a ratio of 1:1. Assessments will take place at weeks 0, 2, 4 and 12 weeks. The assessor will be blind to allocation, t
Sponsors
Oxford Health NHS Foundation Trust
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Male patients of an adult psychiatric inpatient ward 2. Self-reported symptoms of insomnia (Ie. a self-reported difficulty getting to or staying asleep) 3. Would like help to improve their sleep 4. Willing to allow his or her community care team to be notified of participation in the trial 5. Participant is willing and able to given informed consent to participate in the trial
Exclusion criteria
Exclusion criteria: 1. If at the point of screening there are plans for the patient to move to an alternative ward within the following 14 days (prior to week 2 primary end point) 2. The patient lives outside of the region covered by Oxford Health NHS Foundation Trust 3. A command of the English language inadequate for engaging in psychological therapy and comprehending the assessment measures 4. A diagnosis of a learning disability or organic syndrome (e.g. dementia)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Recruitment rate is measured by determining the percentage of participants admitted to the ward who are eligible and consent to take part in the study 2. Rate of uptake of therapy is measured by determining the percentage of participants who complete the intervention and percentage of sessions received from number of sessions offered 3. Accessibility of participant information sheet and informed consent is measure by patient feedback | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Insomnia symptoms is measured using the Insomnia Severity Index questionnaire at weeks 0, 2, 4 and 12 2. Emotional wellbeing is measured using the Warwick Edinburgh Mental Wellbeing Scale at weeks 0, 2, 4 and 12 3. Psychiatric symptoms measured using the Positive and Negative Syndrome Scale and Young Mania Rating Scale at weeks 0, 2, 4 and 12 4. Suicidal ideation measured using the Beck Suicide Scale at weeks 0, 2, 4 and 12 5. Medication use and use of NHS care services is recorded using the Client Service Receipt Inventory at weeks 0, 2, 4 and 12 6. Health related quality of life is assessed using the EQ-5D at weeks 0, 2, 4 and 12 7. Global distress will be measured using the CORE-10 at weeks 0, 2, 4 and 12 | — |
Countries
United Kingdom
Contacts
Public ContactAlvaro Barrera
Outcome results
None listed